CaseVu
Precipio 2018 Revenues Increase 66% Over 2017; Company Takes Substantial Cost-Cutting Measures Towards Profitability
Shareholder call scheduled for February 21st at 4:30PM EST NEW HAVEN, CT, (February 14th, 2019) – [...]
Feb
Makati Medical Center In The Philippines Adopts Precipio’s ICE COLD-PCR Mutation Enrichment Technology For Liquid Biopsies
One of Nation’s Premier Hospitals to Become Central Laboratory for Liquid Biopsies NEW HAVEN, CT, [...]
Jan
Precipio Announces First US Government Customer For ICE COLD-PCR™ Mutation Enrichment Technology
Department of Defense Approves Precipio as a Vendor for its Liquid Biopsy Testing NEW HAVEN, [...]
Jan
Precipio Files Patent For HemeScreen™, Its Novel Molecular Assay
Commercialization of assay underway with both in-house testing and hospital sales NEW HAVEN, CT, (January [...]
Jan
Precipio Reports Strong Mid-Quarter Growth
Key Metrics Indicate Continued Growth QoQ for Fourth Quarter 2018 NEW HAVEN, CT, (December 12th, [...]
Dec
Precipio Announces $1.2 Million Securities Purchase Agreement With Participation From Members Of Its Board Of Directors, And Other Investors
NEW HAVEN, CT, (December 4th, 2018) – Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it [...]
Dec
Precipio Announces Third Quarter 2018 Corporate Update Call For Shareholders
Conference Call to Be Held Monday, November 19, 2018 at 5:00 PM ET NEW HAVEN, [...]
Nov
Proxy And Special Shareholder Meeting Letter From CEO
CEO to share a few thoughts in advance of the upcoming shareholder call on Monday, [...]
Nov
Webinar To Highlight Technology Underlying Precipio’s ICE COLD-PCR On November 20, 2018
Current Status, Existing and Future Applications of COLD-PCR for Cancer and Prenatal Diagnosis to Be [...]
Nov
Precipio And PerkinElmer Collaborate To Provide Solutions For Liquid Biopsy Testing Workflows
Precipio ICE COLD-PCR™ reagents will be sold with PerkinElmer DNA/RNA extraction and isolation products NEW [...]
Nov